Skip to content

Association Between Cytokines and Severity of Respiratory Syncytial Virus (RSV)-Induced Illness in the Elderly

The Association Between Cytokine Genotype Polymorphisms and Severity of RSV-Induced Illness in the Elderly

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00609635
Enrollment
300
Registered
2008-02-07
Start date
2007-11-30
Completion date
2009-04-30
Last updated
2009-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Syncytial Virus Infections

Keywords

Respiratory, RSV-induced respiratory illness

Brief summary

This research study involves studying the genes that may affect how ill you become during respiratory infection with respiratory syncytial virus (RSV). RSV is a virus that often causes common colds. Cytokines are chemicals that are naturally made by your body. Cytokine levels are increased in some people when they have common colds or wheezing caused by respiratory syncytial virus (RSV). The purpose of this study is to study the genes that may control cytokine levels during infection with RSV in the elderly population.

Interventions

None listed

Sponsors

American Academy of Allergy, Asthma, and Immunology
CollaboratorOTHER
West Penn Allegheny Health System
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects \> 65 years of age diagnosed with RSV-induced respiratory illness * Diagnosis (based upon ICD-9-CM codes) for pneumonia, upper respiratory illness, bronchitis, COPD, asthma, viral illness, or congestive heart failure (CHF) * Willing to sign informed consent.

Exclusion criteria

* Not willing to sign informed consent. * Subjects less that 65 years of age * Subjects not diagnosed with a respiratory illness

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026